AU5539596A - Anti-obesity agents - Google Patents

Anti-obesity agents

Info

Publication number
AU5539596A
AU5539596A AU55395/96A AU5539596A AU5539596A AU 5539596 A AU5539596 A AU 5539596A AU 55395/96 A AU55395/96 A AU 55395/96A AU 5539596 A AU5539596 A AU 5539596A AU 5539596 A AU5539596 A AU 5539596A
Authority
AU
Australia
Prior art keywords
obesity agents
obesity
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55395/96A
Inventor
Keith Alan Albrandt
Nigel Beeley
Daniel E. Beidler
Mark Chun
Susan M. Janes
Douglas M. Park
Julie L Phelps
Kathryn S. Prickett
Timothy J Rink
Michael Edward Sierzega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
Original Assignee
Amylin Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC
Publication of AU5539596A publication Critical patent/AU5539596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
AU55395/96A 1995-04-06 1996-04-05 Anti-obesity agents Abandoned AU5539596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41959895A 1995-04-06 1995-04-06
US419598 1995-04-06
PCT/US1996/004909 WO1996031526A1 (en) 1995-04-06 1996-04-05 Anti-obesity agents

Publications (1)

Publication Number Publication Date
AU5539596A true AU5539596A (en) 1996-10-23

Family

ID=23662940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55395/96A Abandoned AU5539596A (en) 1995-04-06 1996-04-05 Anti-obesity agents

Country Status (2)

Country Link
AU (1) AU5539596A (en)
WO (1) WO1996031526A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6001968A (en) * 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
ES2093593T1 (en) * 1995-05-05 1997-01-01 Hoffmann La Roche RECOMBINANT OBESE PROTEINS (OB).
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
US6620413B1 (en) 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
US6541604B1 (en) 1996-01-08 2003-04-01 Genentech, Inc. Leptin receptor having a WSX motif
US7074397B1 (en) 1996-01-08 2006-07-11 Genentech, Inc. Method for enhancing proliferation or differentiation of a cell using ob protein
US20050019325A1 (en) 1996-01-08 2005-01-27 Carter Paul J. WSX receptor agonist antibodies
WO1997046585A2 (en) * 1996-06-06 1997-12-11 Smithkline Beecham P.L.C. Fragments of leptin (ob protein)
AU5802898A (en) * 1996-12-20 1998-07-17 Eli Lilly And Company Anti-obesity proteins
CA2217698A1 (en) * 1996-12-20 1998-06-20 Eli Lilly And Company Anti-obesity proteins
WO1998031391A1 (en) * 1997-01-17 1998-07-23 Eli Lilly And Company Obesity protein formulations
AU5919998A (en) * 1997-01-17 1998-08-07 Eli Lilly And Company Obesity protein formulations
WO1998041222A1 (en) * 1997-03-20 1998-09-24 Eli Lilly And Company Obesity protein formulations
AU4992299A (en) 1998-07-14 2000-02-07 Amylin Pharmaceuticals, Inc. Uncoupling protein 4 (ucp-4) and methods of use
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
SK9432001A3 (en) * 1999-01-07 2003-02-04 Lexigen Pharm Corp Expression and export of anti-obesity proteins as Fc fusion proteins
US6992174B2 (en) 2001-03-30 2006-01-31 Emd Lexigen Research Center Corp. Reducing the immunogenicity of fusion proteins
DE60237100D1 (en) 2001-10-22 2010-09-02 Amgen Inc USE OF LEPTIN FOR THE TREATMENT OF LIPOATROPR PREDICTIVE POSITION AGAINST TREATMENT
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
KR101123549B1 (en) * 2004-11-01 2012-04-18 아밀린 파마슈티칼스, 인크. Treatment of obesity and related disorders
US8394765B2 (en) 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
US7629315B2 (en) * 2005-03-09 2009-12-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compositions for blocking the inhibitory effect of human CRP on human leptin
CA3138758A1 (en) 2010-09-28 2012-04-19 Amylin Pharmaceuticals, Llc Highly soluble leptins
CN110128511B (en) * 2019-05-31 2022-10-25 海南大学 Recombinant protein for losing weight, vaccine and construction method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
AU6524794A (en) * 1993-03-24 1994-10-11 Amylin Pharmaceuticals, Inc. Cloned receptors and methods for screening
US5521283A (en) * 1995-01-31 1996-05-28 Eli Lilly And Company Anti-obesity proteins
US5532336A (en) * 1995-01-31 1996-07-02 Eli Lilly And Company Anti-obesity proteins
US5525705A (en) * 1995-01-31 1996-06-11 Eli Lilly And Company Anti-obesity proteins

Also Published As

Publication number Publication date
WO1996031526A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU5539596A (en) Anti-obesity agents
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU6235496A (en) Azothiophenes
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU7038196A (en) 1-azinyl-tetrazolinones
AU5108596A (en) Morphine-3-esters
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU6840796A (en) Sack-holder
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU7694696A (en) Cyclopeptolides
AU7565396A (en) Fluorobutenoyloxyacetamides
AU6658396A (en) Polyhydroxyalkylamidobetaine
AU7594496A (en) Twinpiano
AU6124596A (en) Mercapto-bis-triazoles